Can L3Harris' Expanding Global Reach Support Future Growth?

L3Harris generated $4.8 billion of international revenue in fiscal 2025, or 22% of total sales, as consolidated revenue rose 3% to $21.865 billion, supported by program ramps and overseas deliveries. Its presence in more than 100 countries and lack of foreign-country revenue concentration above 5% provide diversification and potential growth exposure to international defense demand. Consensus expects EPS growth of 9.79% in 2026 and 14.44% in 2027; LHX trades at 1.89x forward sales versus the industry's 2.26x average.

Analysis

This is not a near-term earnings catalyst: diversified foreign exposure is strategically useful, but it does not establish incremental bookings, backlog conversion, or export-program margins. For LHX, the investable issue is whether international mix shifts toward differentiated communications, ISR, electronic warfare and space payloads, where customer switching costs support margin accretion, rather than lower-margin hardware exports requiring offsets, localization and longer working-capital cycles. A re-rating over the next 6-18 months requires evidence that foreign orders convert into higher segment margins and cash flow, not merely broader sales coverage.

RTX is the stronger pure beneficiary of a broad international rearmament cycle given its installed base and larger export channels, while GD offers more direct upside where land systems and munitions replenishment dominate procurement. LHX may be the better valuation catch-up only if its order growth outpaces peers for two consecutive quarters; otherwise the discount can correctly reflect smaller scale, execution risk and export approval timing. The contrarian view is that defense investors are treating all overseas demand as incremental: European procurement increasingly favors local content, which can pressure U.S. primes' economics and favor European contractors such as RHM.DE, BAE.L and HO.PA.

Over the next 1-3 months, monitor LHX book-to-bill, funded backlog, international order disclosure, segment operating margin and free-cash-flow conversion at results. A weaker-dollar tailwind can help reported foreign sales, but an adverse export-control decision, delayed appropriations, or a decline in international orders relative to domestic programs would falsify the catch-up case. The article's promotional framing and absence of contract-specific data argue against chasing a headline-driven move.

Key Decisions for Investors

• Maintain LHX on watch rather than initiate on this item alone. Upgrade to a 6-12 month long only after reported international orders/book-to-bill exceed 1.0x and management demonstrates stable-to-higher segment margin; exit the thesis if backlog conversion weakens or full-year free-cash-flow guidance is cut.
• For diversified defense exposure, favor a 3-6 month long RTX / short LHX relative-value position after any LHX rally: RTX's international installed base should monetize replenishment demand more reliably, while LHX remains more dependent on proving export execution. Size modestly because a large classified-program award to LHX is the principal upside risk.
• If LHX's next earnings release shows international growth without margin expansion or cash conversion, consider a tactical 1-3 month short LHX versus ITA. The trade targets multiple compression from lower-quality revenue mix; cover on a disclosed major export award, raised earnings guidance, or a material margin beat.
• Do not take exposure to QBTS from this development; no demonstrated procurement, supplier, or revenue linkage connects the quantum name to LHX's international defense opportunity.